An effective treatment in Erdheim Chester disease: vemurafenib: a case report.

Ersin BozanTahir DarçınSamet YamanTuğçe Nur YiğenoğluMerih Kızıl ÇakarMehmet Sinan DalFevzi Altuntaş

Published in: Journal of medical case reports (2023)

BRAF V600E mutation is frequently seen in ECD. Vemurafenib plays an active role in targeted therapy.

Keyphrases